Livara Health is a technology company.
Livara Health provides innovative musculoskeletal care solutions, focusing on personalized care delivery, navigation, and planning to improve patient outcomes.
Livara Health has raised $27.0M across 2 funding rounds.
Livara Health has raised $27.0M in total across 2 funding rounds.
Livara Health has raised $27.0M in total across 2 funding rounds.
Livara Health's investors include 9Yards Capital, ICONIQ Capital, Meritech Capital Partners, Norwest Venture Partners, Polaris Partners, Toba Capital, Andy Cohen.
Livara Health is a value-based musculoskeletal (MSK) care management platform that combines care planning, delivery, and navigation to reduce costs and improve patient outcomes.[1][2][3] It serves medical groups, health systems, health plans, payors, and providers by offering personalized, interdisciplinary care—including virtual physical therapy, pain reprocessing, clinical rounding, and specialist navigation—targeting the biopsychosocial needs of MSK patients to cut unnecessary surgeries, imaging, and pain management by up to 35%.[1][2] Formerly SpineZone, the company has raised $27.6M in funding, including a $15M Series B led by A1 Health Ventures, and operates from San Diego with 81 full-time clinicians and 15-17 years of experience driving growth in patient volume.[3][4][5]
Livara Health originated as SpineZone, founded in 2014 in San Diego, California, initially focusing on spine care through owned clinics in Southern California.[3][4] CEO Darren Cohen, a Nashville native and former private pilot, drew from his career navigating healthcare complexities to address the $400B annual U.S. MSK spend, emphasizing conservative, evidence-based interventions over unnecessary surgeries.[3] In 2022, it rebranded to Livara, expanding to full MSK support (shoulder, hip, knee, spine) and launching as an orthopedic care management system powered by 15 years of clinical research, machine learning, and data-driven protocols.[1][4] Pivotal early traction included 17% patient volume growth in 2022 via its tech platform, now scaled nationally with hybrid virtual/in-person models.[4]
Livara rides the shift to value-based care in MSK, where nearly 1 in 4 members file claims annually amid rising costs from fragmented care.[2] Its timing aligns with payer demands for cost control and hybrid models post-COVID, leveraging AI/data for conservative care over $400B in overtreatment.[3][4] Market forces like risk-bearing providers and health plan pressures favor its 35% cost cuts and outcomes focus, influencing the ecosystem by standardizing biopsychosocial MSK management and enabling scalable virtual access.[1][2][4]
Livara is positioned to expand its Series B-fueled growth, scaling care navigation and clinic networks beyond California while deepening AI integration for predictive outcomes.[3][5] Trends like value-based MSK adoption and hybrid care will propel it, potentially amplifying influence through more payer partnerships and national reach. As MSK costs escalate, Livara's holistic model—rooted in 15+ years of results—could redefine personalized recovery, turning high-cost pain into efficient healing.[1][4]
Livara Health has raised $27.0M across 2 funding rounds. Most recently, it raised $15.0M Series B in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2024 | $15.0M Series B | 9Yards Capital, ICONIQ Capital, Meritech Capital Partners, Norwest Venture Partners, Polaris Partners, Toba Capital, Andy Cohen | |
| Feb 1, 2021 | $12.0M Series A | 9Yards Capital, ICONIQ Capital, Meritech Capital Partners, Norwest Venture Partners, Polaris Partners, Toba Capital, Andy Cohen |